The price-to-earnings ratio for Nu Skin Enterprises, Inc. (NYSE: NUS) is above average at 75.01x. The 36-month beta value for NUS is also noteworthy at 1.11. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 2 rating it as “overweight,” 1 rating it as “hold,” and 1 rating it as “sell.”
The public float for NUS is 48.17M, and at present, short sellers hold a 2.94% of that float. The average trading volume of NUS on April 19, 2024 was 807.70K shares.
NUS) stock’s latest price update
Nu Skin Enterprises, Inc. (NYSE: NUS)’s stock price has gone rise by 2.75 in comparison to its previous close of 12.36, however, the company has experienced a 3.67% increase in its stock price over the last five trading days. InvestorPlace reported 2024-03-18 that Dividends that provide a passive source of revenue for investors often seem great on the surface. Stocks with high yields can sometimes indicate a company’s instability or solely serve the purpose of attracting investors without offering sustainable returns.
NUS’s Market Performance
Nu Skin Enterprises, Inc. (NUS) has experienced a 3.67% rise in stock performance for the past week, with a 0.71% rise in the past month, and a -26.89% drop in the past quarter. The volatility ratio for the week is 3.25%, and the volatility levels for the past 30 days are at 3.49% for NUS. The simple moving average for the last 20 days is 0.08% for NUS’s stock, with a simple moving average of -35.14% for the last 200 days.
Analysts’ Opinion of NUS
Many brokerage firms have already submitted their reports for NUS stocks, with Jefferies repeating the rating for NUS by listing it as a “Hold.” The predicted price for NUS in the upcoming period, according to Jefferies is $39 based on the research report published on January 31, 2023 of the previous year 2023.
BofA Securities gave a rating of “Neutral” to NUS, setting the target price at $58 in the report published on October 02nd of the previous year.
NUS Trading at -5.64% from the 50-Day Moving Average
After a stumble in the market that brought NUS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -69.40% of loss for the given period.
Volatility was left at 3.49%, however, over the last 30 days, the volatility rate increased by 3.25%, as shares sank -0.08% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -28.45% lower at present.
During the last 5 trading sessions, NUS rose by +3.67%, which changed the moving average for the period of 200-days by -62.13% in comparison to the 20-day moving average, which settled at $12.69. In addition, Nu Skin Enterprises, Inc. saw -34.60% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NUS starting from LIPMAN ANDREW D, who sale 2,000 shares at the price of $12.32 back on Mar 25 ’24. After this action, LIPMAN ANDREW D now owns 27,225 shares of Nu Skin Enterprises, Inc., valued at $24,640 using the latest closing price.
LIPMAN ANDREW D, the Director of Nu Skin Enterprises, Inc., sale 2,000 shares at $12.46 during a trade that took place back on Feb 26 ’24, which means that LIPMAN ANDREW D is holding 29,225 shares at $24,920 based on the most recent closing price.
Stock Fundamentals for NUS
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 0.69 for the gross margin
The net margin for Nu Skin Enterprises, Inc. stands at 0.0. The total capital return value is set at 0.04. Equity return is now at value 1.00, with 0.47 for asset returns.
Based on Nu Skin Enterprises, Inc. (NUS), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at 0.23.
Currently, EBITDA for the company is 137.66 million with net debt to EBITDA at 3.13. When we switch over and look at the enterprise to sales, we see a ratio of 0.5. The receivables turnover for the company is 27.02for trailing twelve months and the total asset turnover is 1.09. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.10.
Conclusion
In summary, Nu Skin Enterprises, Inc. (NUS) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
